Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized neoadjuvant metformin plus letrozole vs placebo plus letrozole in ER-positive postmenopausal breast cancer
KCT0000674Phase 2Recruiting
- Sponsor
- Shinpoong Pharma
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in breast cancer comparing Metformin + letrozole with Placebo + letrozole (2 arms). Started Aug 2012; status: recruiting.
02
Drugs
metformin
03
Conditions
breast cancer
Beyond the preview
Go deeper on KCT0000674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000674.